These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 25031013)

  • 1. The combination of CD99 and NKX2.2, a transcriptional target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma.
    Shibuya R; Matsuyama A; Nakamoto M; Shiba E; Kasai T; Hisaoka M
    Virchows Arch; 2014 Nov; 465(5):599-605. PubMed ID: 25031013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma.
    Hung YP; Fletcher CD; Hornick JL
    Mod Pathol; 2016 Apr; 29(4):370-80. PubMed ID: 26847175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation NKX2.2 IHC and
    Pasricha S; Pahwa S; Pruthi M; Jajodia A; Gupta G; Sharma A; Durga G; Kamboj M; Tiwari A; Panigrahi M; Mehta A
    Indian J Pathol Microbiol; 2023; 66(1):58-62. PubMed ID: 36656211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of NKX2.2 Immunohistochemistry for Distinguishing Ewing Sarcoma from Other Sinonasal Small Round Blue Cell Tumors.
    McCuiston A; Bishop JA
    Head Neck Pathol; 2018 Mar; 12(1):89-94. PubMed ID: 28616785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor.
    Folpe AL; Hill CE; Parham DM; O'Shea PA; Weiss SW
    Am J Surg Pathol; 2000 Dec; 24(12):1657-62. PubMed ID: 11117787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NKX2.2 immunohistochemistry in the distinction of Ewing sarcoma from cytomorphologic mimics: Diagnostic utility and pitfalls.
    Russell-Goldman E; Hornick JL; Qian X; Jo VY
    Cancer Cytopathol; 2018 Nov; 126(11):942-949. PubMed ID: 30376220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKX3.1 a useful marker for mesenchymal chondrosarcoma: An immunohistochemical study.
    Syed M; Mushtaq S; Loya A; Hassan U
    Ann Diagn Pathol; 2021 Feb; 50():151660. PubMed ID: 33302222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does PAX7 and NKX2.2 immunoreactivity in Ewing sarcoma have prognostic significance?
    Machado I; Charville GW; Yoshida A; Navarro S; Righi A; Gambarotti M; Scotlandi K; López-Guerrero JA; Llombart-Bosch A
    Virchows Arch; 2022 Apr; 480(4):909-917. PubMed ID: 34985580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma.
    Yoshida A; Sekine S; Tsuta K; Fukayama M; Furuta K; Tsuda H
    Am J Surg Pathol; 2012 Jul; 36(7):993-9. PubMed ID: 22446943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of NKX2.2, a target of EWSR1/FLI1 fusion transcript, in primary renal Ewing sarcoma.
    Yamamoto Y; Yamazaki K; Ishida Y
    J Cytol; 2015; 32(1):30-2. PubMed ID: 25948942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining Ewing and Ewing-like small round cell tumors (SRCT): The need for molecular techniques in their categorization and differential diagnosis. A study of 200 cases.
    Machado I; Navarro L; Pellin A; Navarro S; Agaimy A; Tardío JC; Karseladze A; Petrov S; Scotlandi K; Picci P; Llombart-Bosch A
    Ann Diagn Pathol; 2016 Jun; 22():25-32. PubMed ID: 27180056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis of NKX2.2, ETV4, and BCOR in a large series of genetically confirmed Ewing sarcoma family of tumors.
    Machado I; Yoshida A; López-Guerrero JA; Nieto MG; Navarro S; Picci P; Llombart-Bosch A
    Pathol Res Pract; 2017 Sep; 213(9):1048-1053. PubMed ID: 28864350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ewing Sarcoma of the Female Genital Tract: Clinicopathologic Analysis of 21 Cases With an Emphasis on the Differential Diagnosis of Gynecologic Round Cell, Spindle, and Epithelioid Neoplasms.
    Sharma AE; Wepy CB; Chapel DB; Maccio L; Irshaid L; Al-Ibraheemi A; Dickson BC; Nucci MR; Crum CP; Fletcher CDM; Kolin DL
    Am J Surg Pathol; 2024 Aug; 48(8):972-984. PubMed ID: 38708674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological heterogeneity of Ewing's sarcoma/PNET: an immunohistochemical analysis of 415 genetically confirmed cases with clinical support.
    Llombart-Bosch A; Machado I; Navarro S; Bertoni F; Bacchini P; Alberghini M; Karzeladze A; Savelov N; Petrov S; Alvarado-Cabrero I; Mihaila D; Terrier P; Lopez-Guerrero JA; Picci P
    Virchows Arch; 2009 Nov; 455(5):397-411. PubMed ID: 19841938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evaluation of CD99 immunoreactivity and EWS/FLI1 translocation by fluorescence in situ hybridization in central PNETs and Ewing's sarcoma family of tumors.
    Vural C; Uluoğlu O; Akyürek N; Oğuz A; Karadeniz C
    Pathol Oncol Res; 2011 Sep; 17(3):619-25. PubMed ID: 21267687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of PRKCB Immunohistochemistry as a Biomarker for the Diagnosis of Ewing Sarcoma.
    Zota V; Siegal GP; Kelly D; Bridge JA; Berglund A; Bui K; Khalil F; R Reed D; Altiok S; Magliocco A; Bui MM
    Fetal Pediatr Pathol; 2023 Apr; 42(2):241-252. PubMed ID: 36062956
    [No Abstract]   [Full Text] [Related]  

  • 17. Meningeal Ewing Sarcoma/Peripheral PNET: Clinicopathological, Immunohistochemical and FISH study of four cases.
    Ke Ch; Duan Q; Yang H; Zhu F; Yan M; Xu SP; Zhou S; Wan F; Shu K; Lei T; Xia LM
    Neuropathology; 2017 Feb; 37(1):35-44. PubMed ID: 27500883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of a monoclonal ERG/FLI1 antibody for immunohistochemical discrimination of Ewing family tumors.
    Tomlins SA; Palanisamy N; Brenner JC; Stall JN; Siddiqui J; Thomas DG; Lucas DR; Chinnaiyan AM; Kunju LP
    Am J Clin Pathol; 2013 Jun; 139(6):771-9. PubMed ID: 23690120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis.
    Machado I; Yoshida A; Morales MGN; Abrahão-Machado LF; Navarro S; Cruz J; Lavernia J; Parafioriti A; Picci P; Llombart-Bosch A
    Ann Diagn Pathol; 2018 Jun; 34():1-12. PubMed ID: 29661713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct transcriptional signature and immunoprofile of CIC-DUX4 fusion-positive round cell tumors compared to EWSR1-rearranged Ewing sarcomas: further evidence toward distinct pathologic entities.
    Specht K; Sung YS; Zhang L; Richter GH; Fletcher CD; Antonescu CR
    Genes Chromosomes Cancer; 2014 Jul; 53(7):622-33. PubMed ID: 24723486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.